Talisman Capital Partners

Portfolio · 1

Prilenia Therapeutics

Developing New Treatments for Neurodegenerative Diseases

3 rounds $122.5M committed Latest: 2022-04

Investment activity

Q&A

What is Talisman Capital Partners' primary investment focus by sector?

Talisman Capital Partners primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies in this area.

Can you name a notable company in Talisman Capital Partners' portfolio?

Prilenia Therapeutics, which is developing new treatments for neurodegenerative diseases, is a notable company in Talisman Capital Partners' portfolio.

What is the typical investment range for Talisman Capital Partners?

Talisman Capital Partners typically invests between $11M and $68.5M.

What was Talisman Capital Partners' most recent investment activity?

Talisman Capital Partners had investment activity in April 2022, following an investment in November 2021.

In which funding stages does Talisman Capital Partners typically invest?

Talisman Capital Partners has participated in both A Round and B Round funding stages, with two B Round investments and one A Round investment.

When did Talisman Capital Partners make its first recorded investment?

Talisman Capital Partners made its first recorded investment in June 2020.

Has Talisman Capital Partners made any follow-on investments?

Yes, Talisman Capital Partners has made two follow-on investments, both in B Rounds.

What is the total amount raised by Prilenia Therapeutics, a portfolio company of Talisman Capital Partners?

Prilenia Therapeutics has raised $144.5M in funding, including a B Round investment from Talisman Capital Partners.